IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
This Quarter Return
-7.92%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$443M
AUM Growth
+$443M
Cap. Flow
-$154M
Cap. Flow %
-34.63%
Top 10 Hldgs %
47.3%
Holding
81
New
8
Increased
12
Reduced
20
Closed
11

Top Buys

1
BCRX icon
BioCryst Pharmaceuticals
BCRX
$19.3M
2
NVAX icon
Novavax
NVAX
$18.5M
3
ZLAB icon
Zai Lab
ZLAB
$8.59M
4
AVDL
Avadel Pharmaceuticals
AVDL
$7.65M
5
SNY icon
Sanofi
SNY
$7.64M

Top Sells

1
ALNY icon
Alnylam Pharmaceuticals
ALNY
$51.4M
2
AMGN icon
Amgen
AMGN
$38.1M
3
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
$29.3M
4
INSM icon
Insmed
INSM
$28.8M
5
ITCI
Intra-Cellular Therapies Inc.
ITCI
$25.7M

Sector Composition

1 Healthcare 99.23%
2 Utilities 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
FATE icon
26
Fate Therapeutics
FATE
$120M
$5.64M 1.27% 28,000 – –
LEGN icon
27
Legend Biotech
LEGN
$6.41B
$5.63M 1.27% 4,500 – –
AXSM icon
28
Axsome Therapeutics
AXSM
$6.05B
$5.4M 1.22% +14,000 New +$5.4M
MDGL icon
29
Madrigal Pharmaceuticals
MDGL
$9.76B
$5.07M 1.14% +5,350 New +$5.07M
KDNY
30
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$4.71M 1.06% 340,389 +51,000 +18% +$706K
AUPH icon
31
Aurinia Pharmaceuticals
AUPH
$1.58B
$3.96M 0.89% 435,000 +100,500 +30% +$914K
IONS icon
32
Ionis Pharmaceuticals
IONS
$6.79B
$3.3M 0.74% 154,088 -201,000 -57% -$4.3M
VRTX icon
33
Vertex Pharmaceuticals
VRTX
$100B
$3.23M 0.73% 25,122 -52,100 -67% -$6.69M
XENE icon
34
Xenon Pharmaceuticals
XENE
$2.98B
$3.2M 0.72% 25,500 – –
NBIX icon
35
Neurocrine Biosciences
NBIX
$13.8B
$3.15M 0.71% 203,000 -77,000 -28% -$1.19M
UTHR icon
36
United Therapeutics
UTHR
$13.8B
$2.95M 0.66% +20,000 New +$2.95M
IOVA icon
37
Iovance Biotherapeutics
IOVA
$807M
$2.84M 0.64% 58,000 – –
HARP
38
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$2.77M 0.62% 151,445 -63,555 -30% -$1.16M
INCY icon
39
Incyte
INCY
$16.5B
$2.58M 0.58% 238,000 -47,000 -16% -$509K
IMAB
40
I-MAB
IMAB
$340M
$2.38M 0.54% 18,000 – –
REGN icon
41
Regeneron Pharmaceuticals
REGN
$61.5B
$2.25M 0.51% 12,100 – –
RARE icon
42
Ultragenyx Pharmaceutical
RARE
$2.89B
$2.07M 0.47% 233,100 +95,000 +69% +$845K
ASND icon
43
Ascendis Pharma
ASND
$11.8B
$1.95M 0.44% 29,400 – –
GBT
44
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.64M 0.37% 151,800 +57,000 +60% +$615K
IDYA icon
45
IDEAYA Biosciences
IDYA
$2.15B
$1.62M 0.37% 109,000 – –
TVTX icon
46
Travere Therapeutics
TVTX
$1.56B
$1.55M 0.35% 380,000 – –
APLS icon
47
Apellis Pharmaceuticals
APLS
$3.48B
$1.54M 0.35% 32,500 – –
SWTX
48
DELISTED
SpringWorks Therapeutics
SWTX
$1.38M 0.31% 16,300 -8,700 -35% -$734K
MRTX
49
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.37M 0.31% 188,500 +62,000 +49% +$452K
CCXI
50
DELISTED
ChemoCentryx, Inc.
CCXI
$1.31M 0.3% 36,100 – –
1
2
3 4